stephen.morrison

The global Multiplex Assays Market was valued at $3,470 million in 2015 and is expected to garner $5,720 million by 2022, registering a CAGR of 7.4% during the forecast period 2016-2022. The protein-based

The TAVI market revenue was valued at $2,761 million in 2017 and is expected to reach $8,138 million by 2025, growing at a CAGR of 13.8% from 2018 to 2025. The volume market was valued at 107,011 units

Cardiac Biomarkers Market is expected to garner $2,085.9 million by 2020, registering a CAGR of 18.9% during the period 2015-2020. Cardiac Troponins (T, I) would continue to dominate the market throughout

The U.S. IVF services market was valued at $2,213.1 million in 2015, and is estimated to reach $4,472.2 million by 2022, registering a CAGR of 10.6% from 2016 to 2022. Fresh IVF cycles (non-donor) segment